PMID- 9863527 OWN - NLM STAT- MEDLINE DCOM- 19990302 LR - 20190815 IS - 0142-9612 (Print) IS - 0142-9612 (Linking) VI - 19 IP - 21 DP - 1998 Nov TI - Hydroxyapatite fiber reinforced poly(alpha-hydroxy ester) foams for bone regeneration. PG - 1935-43 AB - A process has been developed to manufacture biodegradable composite foams of poly(DL-lactic-co-glycolic acid) (PLGA) and hydroxyapatite short fibers for use in bone regeneration. The processing technique allows the manufacture of three-dimensional foam scaffolds and involves the formation of a composite material consisting of a porogen material (either gelatin microspheres or salt particles) and hydroxyapatite short fibers embedded in a PLGA matrix. After the porogen is leached out, an open-cell composite foam remains which has a pore size and morphology defined by the porogen. By changing the weight fraction of the leachable component it was possible to produce composite foams with controlled porosities ranging from 0.47 +/- 0.02 to 0.85 +/- 0.01 (n = 3). Up to a polymer:fiber ratio of 7:6, short hydroxyapatite fibers served to reinforce low-porosity PLGA foams manufactured using gelatin microspheres as a porogen. Foams with a compressive yield strength up to 2.82 +/- 0.63 MPa (n = 3) and a porosity of 0.47 +/- 0.02 (n = 3) were manufactured using a polymer:fiber weight ratio of 7:6. In contrast, high-porosity composite foams (up to 0.81 +/- 0.02, n = 3) suitable for cell seeding were not reinforced by the introduction of increasing quantities of hydroxyapatite short fibers. We were therefore able to manufacture high-porosity foams which may be seeded with cells but which have minimal compressive yield strength, or low porosity foams with enhanced osteoconductivity and compressive yield strength. FAU - Thomson, R C AU - Thomson RC AD - Institute of Biosciences and Bioengineering and Department of Chemical Engineering, Rice University, Houston, TX 77005-1892, USA. FAU - Yaszemski, M J AU - Yaszemski MJ FAU - Powers, J M AU - Powers JM FAU - Mikos, A G AU - Mikos AG LA - eng GR - R29-AR42639/AR/NIAMS NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. PT - Research Support, U.S. Gov't, P.H.S. PL - Netherlands TA - Biomaterials JT - Biomaterials JID - 8100316 RN - 0 (Biocompatible Materials) RN - 0 (Polyesters) RN - 0 (Polymers) RN - 1SIA8062RS (Polylactic Acid-Polyglycolic Acid Copolymer) RN - 26009-03-0 (Polyglycolic Acid) RN - 33X04XA5AT (Lactic Acid) RN - 91D9GV0Z28 (Durapatite) SB - IM MH - Biocompatible Materials/*chemistry MH - *Bone Regeneration MH - Compressive Strength MH - Durapatite/*chemistry MH - Guided Tissue Regeneration/*methods MH - Lactic Acid/chemistry MH - Polyesters/*chemistry MH - Polyglycolic Acid/chemistry MH - Polylactic Acid-Polyglycolic Acid Copolymer MH - Polymers/chemistry MH - Porosity OTO - NASA OT - NASA Discipline Cell Biology OT - Non-NASA Center FIR - McIntire, L V IR - McIntire LV IRAD- Rice U, Houston, TX EDAT- 1998/12/24 00:00 MHDA- 1998/12/24 00:01 CRDT- 1998/12/24 00:00 PHST- 1998/12/24 00:00 [pubmed] PHST- 1998/12/24 00:01 [medline] PHST- 1998/12/24 00:00 [entrez] AID - S0142-9612(98)00097-0 [pii] AID - 10.1016/s0142-9612(98)00097-0 [doi] PST - ppublish SO - Biomaterials. 1998 Nov;19(21):1935-43. doi: 10.1016/s0142-9612(98)00097-0.